Fresenius Medical Care North America Announces New Pricing For The Tender Offer And Consent Solicitation For The 9% Senior Subordinated Notes Due 2011 Of Renal Care Group, Inc.

Fresenius Medical Care North America announced today that Florence Acquisition, Inc. ("Florence"), an indirect subsidiary of Fresenius Medical Care AG (Frankfurt Stock Exchange: FME, FME3) (NYSE: FMS, FMS-p) ("FMC-AG"), has determined the new pricing of its previously announced offer to purchase and consent solicitation for any and all of the outstanding $159,685,000 principal amount of 9% Senior Subordinated Notes Due 2011 (the "Notes") of Renal Care Group, Inc.

Back to news